As a result of disruptions that may occur in these pathways due to dysfunctions in the GSK-3β gene, neurological diseases such as AD, PD, Huntington disease, ALS, prion disease, spinocerebellar ataxia and schizophrenia may occur. This evidence concerns the gene GSK3B and cerebellar ataxia.